Avalo Therapeutics, Inc. ($AVTX)
Sullivan Christopher Ryan โ Chief Financial Officer
Shares
3,749
Price
$19.94
Total Value
$74,762.18
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Sullivan Christopher Ryan |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Aug 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Aug 19, 2026 |
| Shares Sold | 3,749 |
| Price per Share | $19.94 |
| Total Value | $74,762.18 |
| Shares Owned After | 39,900 |
| Derivative | No |
| Accession Number | 0001810417-26-000019 |
| Document | View SEC Filing |